McMahon CG. Current diagnosis and management of erectile dysfunction. Med J Aust. 2019;210:469–76.

Article  PubMed  Google Scholar 

Defeudis G, Mazzilli R, Tenuta M, Rossini G, Zamponi V, Olana S, Faggiano A, Pozzilli P, Isidori AM, Gianfrilli D. Erectile dysfunction and diabetes: a melting pot of circumstances and treatments. Diabetes Metab Res Rev. 2022;38:e3494.

Article  PubMed  Google Scholar 

Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50–6.

Article  PubMed  CAS  Google Scholar 

Lowy M, Ramanathan V. Erectile dysfunction: causes, assessment and management options. Aust Prescr. 2022;45:159–61.

Article  PubMed  PubMed Central  Google Scholar 

Xu W, Jiang H, Liu J, Li H. Non-coding RNAs: New Dawn for diabetes mellitus induced erectile dysfunction. Front Mol Biosci. 2022;9:888624.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Patel JP, Lee EH, Mena CI, Walker CN. Effects of metformin on endothelial health and erectile dysfunction. Transl Androl Urol. 2017;6:556–65.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Azarboo A, Behnoush AH, Vaziri Z, Daneshvar MS, Taghvaei A, Jalali A, Cannavo A, Khalaji A. Assessing the association between triglyceride-glucose index and atrial fibrillation: a systematic review and meta-analysis. Eur J Med Res. 2024;29:118.

Article  PubMed  PubMed Central  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.

Article  PubMed  PubMed Central  Google Scholar 

Rew KT, Heidelbaugh JJ. Erectile Dysfunction. Am Fam Physician. 2016;94:820–7.

PubMed  Google Scholar 

Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14:45.

Article  PubMed  PubMed Central  Google Scholar 

Li L, Yao H, Dai W, Chen Y, Liu H, Ding W, Liu Y, Tao L, Wang J, Chen M. A higher TyG index is related with a higher prevalence of erectile dysfunction in males between the ages 20–70 in the United States, according to a cross-sectional research. Front Endocrinol. 2022;13:988257.

Article  Google Scholar 

Mei Y, Li Y, Zhang B, et al. Association between the C-reactive protein-triglyceride glucose index and erectile dysfunction in US males: results from NHANES 2001–2004. Int J Impot Res. 2024. https://doi.org/10.1038/s41443-024-00945-z.

Sun C, Gao Y, Liang Z, Liu C, Chen M. Association of METS-IR index with prevalence of erectile dysfunction in US adults: a cross-sectional study. Int Urol Nephrol. 2024;56:2157–64.

Article  PubMed  Google Scholar 

Xu M, Zhou H, Zhang R, Pan Y, Liu X. Correlation between visceral adiposity index and erectile dysfunction in American adult males: a cross-sectional study based on NHANES. Front Endocrinol. 2023;14:1301284.

Article  Google Scholar 

Peng J, Li D, Liu L, Xiang Y, Tang Y. Comparison of characteristics between Chinese diabetes mellitus-induced erectile dysfunction populations and non-diabetes mellitus-induced erectile dysfunction populations: A cross-sectional study. Front Endocrinol. 2022;13:1096045.

Article  Google Scholar 

Yang S, Zhang Y, Lyu X, Gu Y, Zhang G, Liu P, Zheng Y, Guo Z, Zhang Y, Hou H. The Association Between FGF21 and Diabetic Erectile Dysfunction: Evidence from Clinical and Animal Studies. Front Endocrinol (Lausanne). 2022;13:874796. https://doi.org/10.3389/fendo.2022.874796.

Yao F, Liu L, Zhang Y, Huang Y, Liu D, Lin H, Liu Y, Fan R, Li C, Deng C. Erectile dysfunction may be the first clinical sign of insulin resistance and endothelial dysfunction in young men. Clin Res Cardiol. 2013;102:645–51.

Article  PubMed  CAS  Google Scholar 

Akdemir AO, Karabakan M, Aktas BK, Bozkurt A, Ozgur EG, Akdogan N, Yarıs M. Visceral adiposity index is useful for evaluating obesity effect on erectile dysfunction. Andrologia. 2019;51:e13282.

Article  PubMed  Google Scholar 

Bolat MS, Kocamanoglu F, Ozbek ML, Buyukalpelli R, Asci R. Can High Visceral Adiposity Index Be a Risk Factor for Sexual Dysfunction in Sexually Active Men? J Sex Med. 2020;17:1926–33.

Article  PubMed  CAS  Google Scholar 

Dursun M, Besiroglu H, Cakir SS, Otunctemur A, Ozbek E. Increased visceral adiposity index associated with sexual dysfunction in men. Aging Male. 2018;21:187–92.

Article  PubMed  Google Scholar 

Sambel M, Erdogan A, Caglayan V, Avci S, Kilic S, Yildiz HE, Keskin E: Can atherogenic indices and the triglyceride-glucose index be used to predict erectile dysfunction? Sex Med. 2024;11(6):qfad069.

Yilmaz M, Karaaslan M, Tonyali S, Celik M, Toprak T, Odabas O. Triglyceride-Glucose Index (TyG) is associated with erectile dysfunction: A cross-sectional study. Andrology. 2021;9:238–44.

Article  PubMed  CAS  Google Scholar 

Derosa G, Romano D, Tinelli C, D’Angelo A, Maffioli P. Prevalence and associations of erectile dysfunction in a sample of Italian males with type 2 diabetes. Diabetes Res Clin Pract. 2015;108:329–35.

Article  PubMed  Google Scholar 

Gatti A, Mandosi E, Fallarino M, Radicioni A, Morini E, Maiani F, Trischitta V, Lenzi A, Morano S. Metabolic syndrome and erectile dysfunction among obese non-diabetic subjects. J Endocrinol Invest. 2009;32:542–5.

Article  PubMed  CAS  Google Scholar 

Knoblovits P, Costanzo PR, Rey Valzacchi GJ, Gueglio G, Layus AO, Kozak AE, Balzaretti MI, Litwak LE. Erectile dysfunction, obesity, insulin resistance, and their relationship with testosterone levels in eugonadal patients in an andrology clinic setting. J Androl. 2010;31:263–70.

Article  PubMed  CAS  Google Scholar 

Kim JH, Chung MK, Kang JY, Koh JH, Lee J, Kwok SK, Ju JH, Park SH. Insulin resistance is an independent predictor of erectile dysfunction in patients with gout. Korean J Intern Med. 2019;34:202–9.

Article  PubMed  CAS  Google Scholar 

Aleksandra R, Aleksandra S, Iwona R. Erectile Dysfunction in Relation to Metabolic Disorders and the Concentration of Sex Hormones in Aging Men. Int J Environ Res Public Health. 2022;19:7576.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim JH, Jeon H, Kim SH, Kim H, Yoo J, Chung MK, Koh JH, Lee J, Kwok SK, Ju JH, Park SH. Insulin resistance as an independent predictor of subclinical atherosclerosis in patients with gout. Ann Rheumatic Dis. 2016;75.

Weinberg AE, Eisenberg M, Patel CJ, Chertow GM, Leppert JT. Diabetes Severity, Metabolic Syndrome, and the Risk of Erectile Dysfunction. J Sex Med. 2013;10:3102–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fung MM, Bettencourt R, Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol. 2004;43:1405–11.

Article  PubMed  Google Scholar 

Raheem OA, Su JJ, Wilson JR, Hsieh TC. The association of erectile dysfunction and cardiovascular disease: a systematic critical review. Am J Mens Health. 2017;11:552–63.

Article  PubMed  Google Scholar 

Bagry HS, Raghavendran S, Carli F. Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology. 2008;108:506–23.

Article  PubMed  CAS  Google Scholar 

Kouidrat Y, Pizzol D, Cosco T, Thompson T, Carnaghi M, Bertoldo A, Solmi M, Stubbs B, Veronese N. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med. 2017;34:1185–92.

Article  PubMed  CAS  Google Scholar 

Mazidi M, Kengne AP, Katsiki N, Mikhailidis DP, Banach M. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance. J Diabetes Complications. 2018;32:266–70.

Article  PubMed  Google Scholar 

Mao W, Wu J, Zhang Z, Xu Z, Xu B, Chen M. Neutrophil-lymphocyte ratio acts as a novel diagnostic biomarker for kidney stone prevalence and number of stones passed. Transl Androl Urol. 2021;10:77–86.

Article  PubMed  PubMed Central  Google Scholar 

Roumeguère T, Wespes E, Carpentier Y, Hoffmann P, Schulman CC. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol. 2003;44:355–9.